Vitae Pharmaceuticals, Inc. Hires Christine Brennan, Ph.D. as Chief Business Officer

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. Dr. Brennan has over 10 years experience in business development and strategy roles of increasing responsibility within the biotech, venture and large pharma segments of the biopharmaceutical industry, accumulating a broad range of experiences identifying and matching high-quality science with strategic need. Most recently, Dr. Brennan served as Executive Director and Head of Strategy and Operations for Strategic Alliances at Novartis’ Institutes for BioMedical Research. Prior to Novartis, she worked at Fidelity Biosciences, a private equity venture capital company, and prior to that Dr. Brennan worked in business development for several early-stage biotechnology companies. She holds a Ph.D. in neuroscience from Dartmouth Medical School and a B.S. in biochemistry from the University of New Hampshire.